We are live on
!
Find out more
Tudor Investment Corp Portfolio holdings
AUM
$53.9B
1-Year Est. Return
29.12%
This Fund
S&P 500
This Quarter
Est. Return
+13.42%
1 Year Est. Return
+29.12%
3 Year Est. Return
+77.1%
5 Year Est. Return
+83.79%
10 Year Est. Return
+526.01%
AUM
$45.9B
AUM Growth
+$15.8B
(+53%)
Cap. Flow
+$11.5B
Cap. Flow
% of AUM
25.05%
Top 10 Holdings %
Top 10 Hldgs %
36.72%
Holding
3,886
New
911
Increased
1,361
Reduced
861
Closed
709
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 2 |
Copart
CPRT
|
+$94.6M |
| 3 |
T-Mobile US
TMUS
|
+$89.9M |
| 4 |
Apple
AAPL
|
+$74.3M |
| 5 |
McDonald's
MCD
|
+$72.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$709M |
| 2 |
Broadcom
AVGO
|
+$128M |
| 3 |
K
Kellanova
K
|
+$127M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$89.5M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.62% |
| 2 | Industrials | 3.55% |
| 3 | Financials | 3.32% |
| 4 | Consumer Discretionary | 2.73% |
| 5 | Healthcare | 2.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Stellantis
STLA
$20.2B
| $109K | ﹤0.01% |
10,845
-294,148
| -96% | -$2.9M |
|
3152
Palladyne AI
PDYN
$313M
| $105K | ﹤0.01% |
12,165
-38,929
| -76% | -$276K |
|
3153
Precigen
PGEN
$2.45B
| $101K | ﹤0.01% |
71,464
| – | – |
|
3154
4D Molecular Therapeutics
FDMT
$621M
| $94.2K | ﹤0.01% |
25,379
-20
| -0.1% | -$70 |
|
|
CRGX
3155
DELISTED
CARGO Therapeutics
CRGX
| $93K | ﹤0.01% |
+22,563
| New | +$96.6K |
|
3156
PLAYSTUDIOS Inc
MYPS
$67.3M
| $92.8K | ﹤0.01% |
70,871
| – | – |
|
3157
Senseonics Holdings Inc
SENS
$419M
| $83.1K | ﹤0.01% |
8,719
| – | – |
|
3158
Expensify
EXFY
$202M
| $80.5K | ﹤0.01% |
31,095
-348,337
| -92% | -$890K |
|
3159
Allogene Therapeutics
ALLO
$714M
| $80.2K | ﹤0.01% |
71,008
| – | – |
|
3160
Amylyx Pharmaceuticals
AMLX
$2.6B
| $77.4K | ﹤0.01% |
12,073
-21,355
| -64% | -$104K |
|
3161
IAMGOLD
IAG
$10.3B
| $74.7K | ﹤0.01% |
10,161
-6,850
| -40% | -$48K |
|
3162
New Fortress Energy
NFE
$94M
| $64.2K | ﹤0.01% |
+19,346
| New | +$84.1K |
|
3163
Gossamer Bio
GOSS
$86.8M
| $57.2K | ﹤0.01% |
46,464
| – | – |
|
3164
Alector
ALEC
$240M
| $57.1K | ﹤0.01% |
40,795
-1
| -0% | -$1 |
|
3165
Ironwood Pharmaceuticals
IRWD
$714M
| $57K | ﹤0.01% |
79,455
-2,340
| -3% | -$1.84K |
|
3166
Organogenesis Holdings
ORGO
$233M
| $56.8K | ﹤0.01% |
15,525
-25,053
| -62% | -$93.4K |
|
3167
ImmunityBio
IBRX
$8.2B
| $43.3K | ﹤0.01% |
16,407
-7,846
| -32% | -$21.1K |
|
3168
Zentalis Pharmaceuticals
ZNTL
$307M
| $40.4K | ﹤0.01% |
34,849
| – | – |
|
3169
DocGo
DCGO
$66.2M
| $35.1K | ﹤0.01% |
22,329
| – | – |
|
3170
Pliant Therapeutics
PLRX
$66.3M
| $34.5K | ﹤0.01% |
29,729
-203
| -0.7% | -$287 |
|
3171
CALL
Southland Holdings Warrants
SLND.WS
| $24K | ﹤0.01% |
75,000
| – | – |
|
3172
MacroGenics
MGNX
$256M
| $19.9K | ﹤0.01% |
16,429
| – | – |
|
|
APLT
3173
DELISTED
Applied Therapeutics
APLT
| $17.9K | ﹤0.01% |
57,454
| – | – |
|
3174
Ocugen
OCGN
$475M
| $13.3K | ﹤0.01% |
13,715
-150
| -1% | -$124 |
|
|
SCAGW
3175
CALL
Scage Future Warrants
SCAGW
| $9.01K | ﹤0.01% |
+112,499
| New | +$9.01K |
|
Similar funds
SCP
Tudor Investment Corp's Q2 2025 Portfolio in Review
As of Q2 2025, Tudor Investment Corp held 3,886 positions worth $45.9B, up 53% from $30.1B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Tudor Investment Corp deployed $11.5B of net new capital in Q2 2025, opening 911 new positions and adding to 1,361 existing holdings. Its largest new stake was Copart: 1,690,402 shares worth $82.9M.
By sector, the portfolio is most concentrated in Technology at 4.6% of assets, down from 5.9% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $709M trimmed.
- Tudor Investment Corp's largest Q2 2025 buy was Copart: 1,690,402 shares worth $82.9M.
- Tudor Investment Corp added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $1.08B increase.
- Tudor Investment Corp's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $709M.
- Tudor Investment Corp fully exited Broadcom in Q2 2025, selling an estimated $128M.
- Tudor Investment Corp's ten largest holdings make up 37% of its $45.9B portfolio in Q2 2025.
- Tudor Investment Corp opened 911 new positions and closed 709 in Q2 2025.
- Tudor Investment Corp's portfolio value rose 53% quarter-over-quarter to $45.9B.
Based on Tudor Investment Corp's 13F filing for Q2 2025, filed 14 Aug 2025.